📰 Sera Prognostics News
Page 14 - Sera Prognostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sera Prognostics. Real-time updates on events, politics, business and more.
November 4, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
November 3, 2021
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
November 2, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
October 27, 2021
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
July 15, 2021
Sera Prognostics Announces Pricing of Initial Public Offering July 14, 2021 21:03 ET | Source: Sera Prognostics Sera Prognostics SALT LAKE CITY, July 14, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company ® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the pricing of its initial public offering of 4,687,500 shares of its common stock...
May 29, 2021
Quality insights about the market research are delivered via an outstanding Preeclampsia Drugs Market report by keeping in mind the way people live, b
May 23, 2021
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
April 30, 2021
Photo by Ariel Skelley/Getty Images Halma, a UK-based health tech company, snapped up perinatal and prenatal health AI company PeriGen for $58 million earlier this week. Founded in 2000, PeriGen makes software products focused on the childbirth process that give clinicians more patient data based on algorithms and analysis. Its Early Warning System and Clinical Decision Support tool is able to use artificial intelligence to monitor patients in labor and find any potential issues that need to b...
April 29, 2021
Published: Apr 29, 2021 By Alex Keown Less than one year after launching, Ohio-based Forge Biologics secured $120 million in a Series B financing round to support the clinical development of its gene therapy program for rare diseases, including the typically fatal Krabbe disease. In an announcement this morning, Forge said the proceeds from the Series B program will be used to accelerate the expansion of its AAV manufacturing CDMO capabilities with cGMP production capacity and ope...
April 5, 2021
Search jobs 05-Apr-2021 Preterm Birth Diagnostic Test Kits Market 2021: Global Trends, Growth Analysis, Opportunities and Forecast Report to 2028 | Creative Diagnostics, Qiagen, Medixbiochemcia, Hologic Inc, Sera Prognostics, IQ Products | FMI Report A new study by the company titled ‘Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028’, has listed out the key points being considered ...